These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15261132)

  • 21. Regadenoson for myocardial perfusion scintigraphy.
    Reyes E; Pennell DJ
    Expert Opin Med Diagn; 2010 Sep; 4(5):447-54. PubMed ID: 23496201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial.
    Gaemperli O; Schepis T; Koepfli P; Siegrist PT; Fleischman S; Nguyen P; Olmsted A; Wang W; Lieu H; Kaufmann PA
    J Am Coll Cardiol; 2008 Jan; 51(3):328-9. PubMed ID: 18206744
    [No Abstract]   [Full Text] [Related]  

  • 23. Regadenoson.
    Bengalorkar GM; Bhuvana K; Sarala N; Kumar TN
    J Postgrad Med; 2012; 58(2):140-6. PubMed ID: 22718059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of coronary stenosis with myocardial contrast echocardiography using regadenoson, a selective adenosine A2A receptor agonist.
    Le DE; Bragadeesh T; Zhao Y; Wang YG; Zha D; Kaul S
    Eur Heart J Cardiovasc Imaging; 2012 Apr; 13(4):298-308. PubMed ID: 22067143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation.
    Riou LM; Ruiz M; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA; Glover DK
    J Am Coll Cardiol; 2002 Nov; 40(9):1687-94. PubMed ID: 12427424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson.
    Noel CV; Krishnamurthy R; Moffett B; Krishnamurthy R
    Pediatr Radiol; 2017 Mar; 47(3):280-289. PubMed ID: 28035425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.
    Hage FG; Heo J; Franks B; Belardinelli L; Blackburn B; Wang W; Iskandrian AE
    Am Heart J; 2009 Apr; 157(4):771-6. PubMed ID: 19332209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requisite roles of A2A receptors, nitric oxide, and KATP channels in retinal arteriolar dilation in response to adenosine.
    Hein TW; Yuan Z; Rosa RH; Kuo L
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2113-9. PubMed ID: 15914631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of caffeine and theophylline on coronary hyperemia induced by adenosine or dipyridamole.
    Salcedo J; Kern MJ
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):598-605. PubMed ID: 19496111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A2A adenosine-receptor-mediated facilitation of noradrenaline release in rat tail artery involves protein kinase C activation and betagamma subunits formed after alpha2-adrenoceptor activation.
    Fresco P; Oliveira JM; Kunc F; Soares AS; Rocha-Pereira C; Gonçalves J; Diniz C
    Neurochem Int; 2007 Jul; 51(1):47-56. PubMed ID: 17493708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adenosine 2A receptor agonist ATL-146e attenuates experimental posthemorrhagic vasospasm.
    Chang CZ; Dumont AS; Simsek S; Titus BJ; Kwan AL; Kassell NF; Solenski NJ
    Neurosurgery; 2007 Jun; 60(6):1110-7; discussion 1117-8. PubMed ID: 17538386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
    Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels.
    Hein TW; Belardinelli L; Kuo L
    J Pharmacol Exp Ther; 1999 Nov; 291(2):655-64. PubMed ID: 10525085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes.
    Brambilla R; Cottini L; Fumagalli M; Ceruti S; Abbracchio MP
    Glia; 2003 Aug; 43(2):190-4. PubMed ID: 12838511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in pharmacologic agents in imaging: new A2A receptor agonists.
    Cerqueira MD
    Curr Cardiol Rep; 2006 Mar; 8(2):119-22. PubMed ID: 16524538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.
    El-Tayeb A; Iqbal J; Behrenswerth A; Romio M; Schneider M; Zimmermann H; Schrader J; Müller CE
    J Med Chem; 2009 Dec; 52(23):7669-77. PubMed ID: 19580286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age and gender as predictors of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: a substudy of the ASSUAGE trial.
    Rangel MO; Demori RM; Doukky R
    Am J Ther; 2013; 20(6):622-9. PubMed ID: 24100259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic manipulation of coronary vascular physiology for the evaluation of coronary artery disease.
    Farhad H; Murthy VL
    Pharmacol Ther; 2013 Nov; 140(2):121-32. PubMed ID: 23756132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.